Systematic review of intraocular pressure-lowering effects of adjunctive medications added to latanoprost

Ophthalmic Research

Volumn 42, Issue 2, 2009, Pages 99-105

  Cheng, Jin Wei ^a   Li, You ^a   Wei, Rui Li ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Brimonidine; Brinzolamide; Dorzolamide; Intraocular pressure; Latanoprost; Timolol maleate

Indexed keywords

ANTIGLAUCOMA AGENT; BRIMONIDINE; BRINZOLAMIDE; BUNAZOSIN; CARTEOLOL; DORZOLAMIDE; LATANOPROST; NIPRADILOL; TIMOLOL;

ADD ON THERAPY; ADJUVANT THERAPY; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG WITHDRAWAL; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; OPEN ANGLE GLAUCOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT DURATION;

AGED; ANTIHYPERTENSIVE AGENTS; DATABASES, FACTUAL; DRUG THERAPY, COMBINATION; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPTIC NERVE DISEASES; PROSTAGLANDINS F, SYNTHETIC; QUINOXALINES; SULFONAMIDES; THIAZINES; THIOPHENES; TIMOLOL;

EID: 67449164217     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000225963     Document Type: Article

References (28)

1. Alward WL: Medical management of glaucoma. N Engl J Med 1998;339:1298-1307.
2. AGIS Investigators: The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000;130:429-440.
3. Hurvitz LM, Kaufman PL, Robin AL, Weinreb RN, Crawford K, Shaw B: New developments in the drug treatment of glaucoma. Drugs 1991;41:514-532. (Pubitemid 21920739)
4. Resul B, Stjernschantz J, No K, Liljebris C, Selén G, Astin M, Karlsson M, Bito LZ: Phenyl-substituted prostaglandins: potent and selective antiglaucoma agents. J Med Chem 1993;36:243-248.
5. Alm A: Prostaglandin derivates as ocular hypotensive agents. Prog Retin Eye Res 1998;17:291-312.
6. Alexander CL, Miller SJ, Abel SR: Prostaglandin analog treatment of glaucoma and ocular hypertension. Ann Pharmacother 2002;36:504-511. (Pubitemid 34205326)
7. Zhang WY, Po AL, Dua HS, Azuara-Blanco A: Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension. Br J Ophthalmol 2001;85:983-990.
8. Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A, Mallick S, Dickerson J, Bergamini MV, Robertson SM, Davis AA; Travoprost Study Group: Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol 2001;132:472-484. (Pubitemid 32904567)
9. Noecker RS, Dirks MS, Choplin NT, Bernstein P, Batoosingh AL, Whitcup SM; Bimatoprost/Latanoprost Study Group: A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am J Ophthalmol 2003;135:55-63. (Pubitemid 36020425)
10. Choplin N, Bernstein P, Batoosingh AL, Whitcup SM;Bimatoprost/Latanoprost Study Group: A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure. Surv Ophthalmol 2004;49:S19-S25.
11. van der Valk R, Webers CA, Schouten JS, Zeegers MP, Hendrikse F, Prins MH: Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials. Ophthalmology 2005;112:1177-1185. (Pubitemid 40916921)
12. Verhagen AP, de Vet HC, de Bie RA, Kessels AG, Boers M, Bouter LM, Knipschild PG: The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998;51:1235-1241. (Pubitemid 29009523)
13. DerSimonian R, Kacker R: Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 2007;28:105-114. (Pubitemid 44937874)
14. Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634. (Pubitemid 27387172)
15. Stewart WC, Day DG, Sharpe ED, Dubiner HB, Holmes KT, Stewart JA: Efficacy and safety of timolol solution once daily vs. timolol gel added to latanoprost. Am J Ophthalmol 1999;128:692-696.
16. Maruyama K, Shirato S, Haneda M: Evaluation of the additive effect of bunazosin on latanoprost in primary open-angle glaucoma. Jpn J Ophthalmol 2005;49:61-62. (Pubitemid 40249005)
17. Kobayashi H, Kobayashi K, Okinami S: Efficacy of bunazosin hydrochloride 0.01% as adjunctive therapy of latanoprost or timolol. J Glaucoma 2004;13:73-80. (Pubitemid 38112358)
18. Konstas AG, Karabatsas CH, Lallos N, Georgiadis N, Kotsimpou A, Stewart JA, Stewart WC: Twenty-four-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects. Ophthalmology 2005;112:603-608. (Pubitemid 41108860)
19. Haneda M, Shirato S, Maruyama K, Ohno Y: Comparison of the additive effects of nipradilol and carteolol to latanoprost in open-angle glaucoma. Jpn J Ophthalmol 2006;50:33-37. (Pubitemid 43201031)
20. Maruyama K, Shirato S: Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial. J Glaucoma 2006;15:341-345. (Pubitemid 44126911)
21. Tamer C, Oksüz H: Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost. Ophthalmic Res 2007;39:24-31. (Pubitemid 46098881)
22. Day DG, Hollander DA: Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension. Curr Med Res Opin 2008;24:1435-1442.
23. Miura K, Ito K, Okawa C, Sugimoto K, Matsunaga K, Uji Y: Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost. J Glaucoma 2008;17:233-237. (Pubitemid 351543550)
24. Maier PC, Funk J, Schwarzer G, Antes G, Falck-Ytter YT: Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials. BMJ 2005;331:134-139. (Pubitemid 41003170)
25. Palmberg P: Evidence-based target pressures: how to choose and achieve them. Int Ophthalmol Clin 2004;44:1-14.
26. Diestelhorst M, Larsson LI; European Latanoprost Fixed Combination Study Group: A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension. Br J Ophthalmol 2004;88:199-203.
27. Diestelhorst M, Larsson LI;European-Canadian Latanoprost Fixed Combination Study Group: A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components. Ophthalmology 2006;113:70-76.
28. Olthoff CM, Schouten JS, van de Borne BW, Webers CA: Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology 2005;112:953-961.